As described in a new manuscript published in the journal Cancers, 26% of sinonasal squamous cell carcinomas have detectable HPV. Interestingly, HPV prevalence was higher in subsites with high exposure to
The Faden Lab received an NIH K23 grant entitled “Dissecting temporal and spatial dynamics of immunotherapy resistance.”
Read about the Head and Neck Cancer Stereotactic Radiosurgery Program, here
An international multicenter consortium of investigators, including the Faden lab, conducted the largest study to date a characterizing the somatic mutational landscape of oral tongue cancers from young patients without
VTX-2337-HN-001 A Phase 1b Multicenter Pre-Surgical Study to Evaluate Immune Biomarker Modulation in Response to Motolimod (VTX-2337) in Combination with Nivolumab in Subjects with Resectable Squamous Cell Carcinoma of the
The Faden lab, in collaboration with the laboratory of Shannon Stott, PhD, recieved funding from Harvard Catalyst to study how cells change across time and space in response to immunotherapy.
The Faden lab recieved the 2020 Translational Innovator Award from the American Head and Neck Society and the American Academy of Otolaryngology- Head and Neck Surgery. This award provides funding
The Faden Lab recieved funding from the American College of Surgeons to study Liquid Biopsy approaches in Head and Neck Cancer.
